NeoGenomics Laboratories
www.neogenomics.comNeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. We work every day to achieve our common purpose of saving lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. Our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor FISH testing with the largest menu of technical-only services available; 10-color flow cytometry; IHC supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. Our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out FISH, flow cytometry, and/or IHC. NeoGenomics’ extremely fast test development cycle means we are highly responsive to therapy development and guideline changes, and test design always involves a balance of convention and innovation. We support clients in many cancer-related market segments, to include: hospital and private pathology laboratories, office-based oncologists, CRO / Biopharmaceutical development organizations, academic institutions / teaching hospitals, and several more. CONNECT WITH US Online: neogenomics.com Twitter: https://twitter.com/NeoGenomics Facebook: facebook.com/neogenomics
Read moreNeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. We work every day to achieve our common purpose of saving lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. Our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor FISH testing with the largest menu of technical-only services available; 10-color flow cytometry; IHC supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. Our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out FISH, flow cytometry, and/or IHC. NeoGenomics’ extremely fast test development cycle means we are highly responsive to therapy development and guideline changes, and test design always involves a balance of convention and innovation. We support clients in many cancer-related market segments, to include: hospital and private pathology laboratories, office-based oncologists, CRO / Biopharmaceutical development organizations, academic institutions / teaching hospitals, and several more. CONNECT WITH US Online: neogenomics.com Twitter: https://twitter.com/NeoGenomics Facebook: facebook.com/neogenomics
Read moreCountry
State
Florida
City (Headquarters)
Fort Myers
Industry
Employees
1001-5000
Founded
2002
Estimated Revenue
$50,000,000 to $100,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Medical Officer , Clinical Services
Email ****** @****.comPhone (***) ****-****Director ( Board of Directors )
Email ****** @****.comPhone (***) ****-****Medical Director
Email ****** @****.comPhone (***) ****-****Director , Global Public Relations and Events
Email ****** @****.comPhone (***) ****-****
Technologies
(204)